| 12327613 |
De novo antibody design |
Terence Seward Baker, Xiaofeng Liu, Richard David Taylor |
2025-06-10 |
| 11942188 |
Obtaining an improved therapeutic ligand |
Terence Seward Baker, Alastair David Griffiths Lawson, Xiaofeng Liu |
2024-03-26 |
| 11702468 |
Antibodies specific for sclerostin and methods for increasing bone mineralization |
David G. Winkler, John Latham |
2023-07-18 |
| 9771420 |
Methods of treating an IL-17A mediated pathological condition |
Thomas Allen Ceska, Alistar James Henry |
2017-09-26 |
| 9657095 |
Antibodies specific for sclerostin and methods for increasing bone mineralization |
David G. Winkler, John Latham |
2017-05-23 |
| 9045537 |
Antibodies specific to IL-17A and IL-17F |
Thomas Allen Ceska, Alistar James Henry |
2015-06-02 |
| 9011856 |
Antibodies specific for sclerostin and methods for increasing bone mineralization |
David G. Winkler, John Latham |
2015-04-21 |
| 8992911 |
Antibodies specific for sclerostin and methods for increasing bone mineralization |
David G. Winkler, John Latham |
2015-03-31 |
| 8563271 |
Antibodies specific for sclerostin and methods for increasing bone mineralization |
David G. Winkler, John Latham |
2013-10-22 |
| 7985834 |
Compositions and methods for increasing bone mineralization |
David G. Winkler, John Latham |
2011-07-26 |
| 7868134 |
Immunogenic peptides derived from sclerostin |
David G. Winkler, John Latham |
2011-01-11 |
| 7578999 |
Antibodies specific for sclerostin |
David G. Winkler, John Latham |
2009-08-25 |
| 7381409 |
Antibodies specific for sclerostin and methods of screening and use therefor |
David G. Winkler, John Latham |
2008-06-03 |